Company profile
Ticker
FBLG
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
IRS number
863329066
FBLG stock data
Latest filings (excl ownership)
S-1/A
IPO registration (amended)
15 May 24
S-8
Registration of securities for employees
15 May 24
10-Q
2024 Q1
Quarterly report
14 May 24
8-K
Other Events
26 Apr 24
S-1
IPO registration
25 Apr 24
EFFECT
Notice of effectiveness
29 Mar 24
424B4
Prospectus supplement with pricing info
28 Mar 24
S-1/A
IPO registration (amended)
26 Mar 24
S-1/A
IPO registration (amended)
15 Mar 24
10-K
2023 FY
Annual report
29 Feb 24
Latest ownership filings
Financial summary
Quarter (USD) | Mar 24 | Dec 23 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Annual (USD) | Dec 23 | |
---|---|---|
Revenue | ||
Cost of revenue | ||
Operating income | ||
Operating margin | ||
Net income | ||
Net profit margin | ||
Cash on hand | ||
Change in cash | ||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | |||
---|---|---|---|---|---|---|
Cash on hand (at last report) | 8.16 mm | 8.16 mm | ||||
Cash burn (monthly) | 1.15 mm | 1.43 mm | ||||
Cash used (since last report) | 2.44 mm | 3.02 mm | ||||
Cash remaining | 5.72 mm | 5.13 mm | ||||
Runway (months of cash) | 5.0 | 3.6 |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Mar 24 | Ruben A Garcia | Stock Option Common Stock | Grant | Acquire A | No | No | 13 | 180,000 | 2.34 mm | 180,000 |
News
FibroBiologics, Charles River Laboratories Sign Letter Of Intent Allowing For Transfer, Testing And Validation Of Technology
25 Apr 24
Ally Financial Reports Upbeat Earnings, Joins Badger Meter, Genuine Parts And Other Big Stocks Moving Higher On Thursday
18 Apr 24
FibroBiologics Granted Patent For Regeneration Of Cartilage-Type Cells By The Australian Patent Office
11 Apr 24
FibroBiologics Presents Data From Dermal Fibroblast Spheroid-Based Treatment Of Chronic Wounds In A Diabetes Mouse Model At Advanced Wound Care Summit USA
4 Apr 24
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
20 Mar 24
Press releases
FibroBiologics Announces 2024 Annual Meeting of Stockholders
15 May 24
FibroBiologics Files 2024 First Quarter Report
14 May 24
FibroBiologics to Present at the BIO International Convention 2024
7 May 24
FibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent Office
11 Apr 24
FibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a Diabetes Mouse Model at Advanced Wound Care Summit USA
4 Apr 24